Enanta Pharmaceuticals, Inc. Stock Performance

Open $12.17	Prev. Close $12.14	Circuit Range N/A
Day Range $12.11 - $12.60	Year Range $10.31 - $17.11	Volume 21,604
Average Traded $12.36

Enanta Pharmaceuticals, Inc. Share Price Today

As of 10 October 2026, Enanta Pharmaceuticals, Inc.'s share price is $12.50. The stock opened at $12.17, compared to its previous close of $12.14. During today's trading session, Enanta Pharmaceuticals, Inc.'s share price traded between $12.11 and $12.60, with an average price of $12.36. Over the past 52 weeks, the stock has recorded a high of $17.11 and a low of $10.31. In terms of performance, Enanta Pharmaceuticals, Inc.'s share price has declined by 9.88% over the last six months and is up 14.47% on a year-on-year basis.

Enanta Pharmaceuticals, Inc. Share Price Chart

$12.11$12.60

Enanta Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators

Market Cap $266700.00	PE Ratio (TTM) N/A	Dividend Yield 0.00%
EPS (TTM) $-2.17	Revenue (TTM) $65.32B	Return On Equity (TTM) -62.56%
Profit Margin -125.37%	Debt to Equity 0.00	Quarterly Earnings Growth YoY -4.28%

Enanta Pharmaceuticals, Inc. Quarterly Profit & Loss

All figures in USD

Particulars	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	$15.13	$18.62	$17.16	$14.36
Net Profit	-$18.70	-$11.94	-$13.09	-$19.50
Net Profit Margin	-123.60%	-64.12%	-76.28%	-135.79%
Income Change	N/A	36.15%	-9.63%	-48.97%

Enanta Pharmaceuticals, Inc. Annual Profit & Loss

All figures in USD

Particulars	2022	2023	2024	2025
Revenue	$86.16	$79.20	$67.64	$65.32
Net Profit	-$121.76	-$133.82	-$116.05	-$81.89
Net Profit Margin	-141.32%	-168.96%	-171.57%	-125.37%
Income Change	N/A	-9.90%	13.28%	29.44%

About Enanta Pharmaceuticals, Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

Enanta Pharmaceuticals, Inc. Historical Returns

Month	Open	Close	Change %
Oct 2026	$13.43	$12.48	-5.42%
Sep 2026	$13.34	$13.20	-4.21%
Aug 2026	$12.47	$13.78	+9.45%
Jul 2026	$14.83	$12.59	-13.50%
Jun 2026	$13.09	$14.55	+10.77%
May 2026	$13.92	$13.14	-5.26%
Apr 2026	$12.96	$13.87	+10.04%
Mar 2026	$14.14	$12.61	-11.17%
Feb 2026	$13.11	$14.19	+9.91%
Jan 2026	$15.35	$12.91	-18.63%
Dec 2025	$14.23	$15.87	+12.36%
Nov 2025	$11.03	$14.12	+29.30%

ENTA Share Price FAQs

What is Enanta Pharmaceuticals, Inc. share price today?

Enanta Pharmaceuticals, Inc. share price today is $12.50 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Enanta Pharmaceuticals, Inc. stock?

The 52 week high of Enanta Pharmaceuticals, Inc. stock is $17.11, while the 52 week low is $10.31 as of 10 Oct '26.

What is ENTA's market capitalisation today?

ENTA market capitalisation is $266700.00 as of October 10, 2026, at 6:22 pm IST.

What is ENTA's net income for the last quarter?

ENTA's net income for the last quarter is -19.50B USD.

What is the 5 year returns of ENTA?

The 5 year returns of ENTA is -85.44% as on 10 Oct '26.

What is the high & low stock price of ENTA today?

ENTA stock price hit a high of $12.60 and low of $12.11 as of 10 Oct '26.

Can I buy ENTA shares in India?

Yes. You can buy ENTA in India by opening an international trading account.